Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway

被引:54
作者
Jozwiak, J
Jozwiak, S
Grzela, T
Lazarczyk, M
机构
[1] Med Univ Warsaw, Dept Histol & Embryol, Ctr Biostruct Res, PL-02004 Warsaw, Poland
[2] Childrens Mem Hlth Inst, Dept Pediat Neurol, Warsaw, Poland
[3] Med Univ Warsaw, Dept Dermatol, PL-02004 Warsaw, Poland
关键词
tuberous sclerosis (TSC); mTOR; hamartin; tuberin;
D O I
10.1385/NMM:7:4:287
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tuberous sclerosis is an autosomal-dominant disorder caused by the mutation of one of the two tumor suppressor genes: TSC1 or TSC2, encoding protein products, hamartin, and tuberin, respectively. Both proteins form intracellular complexes exerting inhibitory activity on mammalian target of rapamycin (mTOR) kinase. It has been demonstrated that signal transduction from tuberin to mTOR is mediated by a G protein, Ras homologue enriched in brain (Rheb). In normal cells, tuberin having GTPase-activating protein properties toward Rheb controls signals of nutrient depletion, hypoxia, or stress, not allowing activation of mTOR and subsequent protein translation and cell proliferation. However, when environmental conditions change, tuberin is phosphorylated and it forms a complex with hamartin is degraded, and downstream targets of mTOR, S6K, and eEF2K, can be activated. In this review, we summarize very recent information contributing to our knowledge of TSC2 regulation by four cellular signaling pathways: PI3K/Akt, Ras/MAPK, LKB1/AMPK, and REDD1.
引用
收藏
页码:287 / 296
页数:10
相关论文
共 54 条
[1]   Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors [J].
Ballif, BA ;
Roux, PP ;
Gerber, SA ;
MacKeigan, JP ;
Blenis, J ;
Gygi, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :667-672
[2]   Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex [J].
Brugarolas, J ;
Lei, K ;
Hurley, RL ;
Manning, BD ;
Reiling, JH ;
Hafen, E ;
Witter, LA ;
Ellisen, LW ;
Kaelin, WG .
GENES & DEVELOPMENT, 2004, 18 (23) :2893-2904
[3]   Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner [J].
Castro, AF ;
Rebhun, JF ;
Clark, GJ ;
Quilliam, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) :32493-32496
[4]   Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status [J].
Cheng, SWY ;
Fryer, LGD ;
Carling, D ;
Shepherd, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) :15719-15722
[5]   Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome [J].
Corradetti, MN ;
Inoki, K ;
Bardeesy, N ;
DePinho, RA ;
Guan, KL .
GENES & DEVELOPMENT, 2004, 18 (13) :1533-1538
[6]   RETRACTED: Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin (Retracted Article) [J].
Dan, HC ;
Sun, M ;
Yang, L ;
Feldman, RI ;
Sui, XM ;
Ou, CC ;
Nellist, M ;
Yeung, RS ;
Halley, DJJ ;
Nicosia, SV ;
Pledger, WJ ;
Cheng, JQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) :35364-35370
[7]   REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species [J].
Ellisen, LW ;
Ramsayer, KD ;
Johannessen, CM ;
Yang, A ;
Beppu, H ;
Minda, K ;
Oliner, JD ;
McKeon, F ;
Haber, DA .
MOLECULAR CELL, 2002, 10 (05) :995-1005
[8]   The pleckstrin homology domain proteins Slm1 and Slm2 are required for actin cytoskeleton organization in yeast and bind phosphatidylinositol-4,5-bisphosphate and TORC2 [J].
Fadri, M ;
Daquinag, A ;
Wang, S ;
Xue, T ;
Kunz, J .
MOLECULAR BIOLOGY OF THE CELL, 2005, 16 (04) :1883-1900
[9]   Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling [J].
Gao, XS ;
Zhang, Y ;
Arrazola, P ;
Hino, O ;
Kobayashi, T ;
Yeung, RS ;
Ru, BG ;
Pan, DJ .
NATURE CELL BIOLOGY, 2002, 4 (09) :699-704
[10]   TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth [J].
Gao, XS ;
Pan, DJ .
GENES & DEVELOPMENT, 2001, 15 (11) :1383-1392